Skip to main content
NVAX logo

NVAX · Novavax Inc · Investor Relations

Track NVAX — free
$10.46 -0.14 (-1.32%) At close · Oct 2
Market Cap
$1.75B
Shares
164.95M
Volume · Oct 2 4.03M Avg daily vol (3M) 4.45M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-09-10 Citi’s 2026 BioPharma Back to School Conference Conference
2026-09-09 2026 Cantor Global Healthcare Conference Conference
2026-08-06 Novavax to Report Second Quarter 2026 Financial Results Earnings call
2026-06-04 Jefferies Global Healthcare Conference Conference
2026-05-13 Bank of America Securities 2026 Healthcare Conference Conference
2026-05-06 Novavax to Report First Quarter 2026 Financial Results Earnings call
2026-03-11 Jefferies Biotech on the Beach Summit Event
2026-03-10 Leerink Partners 2026 Global Healthcare Conference Conference
2026-03-03 TD Cowen 46th Annual Health Care Conference Conference
2026-02-26 Novavax to Report Fourth Quarter and Full Year 2025 Financial Results Earnings call
2026-01-14 Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference Conference
2025-11-19 Jefferies London Healthcare Conference Conference
2025-11-06 Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025 Event
2025-09-04 Novavax to Participate in the Cantor Global Healthcare Conference Conference
2025-08-06 Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025 Event

Source: https://ir.novavax.com/

Key facts CIK 1000694 CUSIP 670002401 13F (30d) 5 filings 5 filers Visit website Investor relations